(Q39357739)

English

AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker

scientific article published on 21 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymph node metastasis

1 reference

based on heuristic

inferred from title

author name string

Jun Ma

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Di-Xian Luo

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Chenfei Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yi Shen

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Yiwen Bu

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Stephen Markwell

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

John Gao

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Jianghua Liu

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Xuyu Zu

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Zhe Cao

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Zachary Gao

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Fengmin Lu

12

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Duan-Fang Liao

13

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Deliang Cao

14

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

21 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

131

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

E862-71

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Therapeutic strategies for triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Molecular profiling in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Identification and characterization of a novel human aldose reductase-like gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived alpha, beta-unsaturated carbonyls at physiological levels

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Human aldo-keto reductases 1B1 and 1B10: a comparative study on their enzyme activity toward electrophilic carbonyl compounds

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Fibrates in the chemical action of daunorubicin.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

AKR1B10 in usual interstitial pneumonia: expression in squamous metaplasia in association with smoking and lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Aldo-keto reductase family 1, member B10 is secreted through a lysosome-mediated non-classical pathway

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Systems analysis of protein modification and cellular responses induced by electrophile stress

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Cancer metastasis: building a framework

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Serum tumor markers in breast cancer: are they of clinical value?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Biomarkers for early detection of breast cancer: what, when, and where?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Proliferation marker Ki-67 in early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

HER-2 and topoisomerase II as predictors of response to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Serial determination of CEA and CA 15.3 in breast cancer follow-up: an assessment of their diagnostic accuracy for the detection of tumour recurrences.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.27618

21 January 2018

Identifiers

10.1002/IJC.27618

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39357739&oldid=1822851143"